1
|
Promising Anticancer Activity of β-Carboline Derivatives: Design, Synthesis, and Pharmacological Evaluation. CHEMISTRY 2022. [DOI: 10.3390/chemistry4040091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
β-carboline consists of a pyridine ring fused to an indole skeleton; it possesses numerous pharmacological activities, including anticancer. Previously, we reported a satisfactory 2D and 3D QSAR study on β-carboline derivatives. Based on QSAR studies, we designed, synthesized, characterized, and screened fourteen β-carboline derivatives for anticancer activity. Eleven of them demonstrated potent anticancer activity against both liver (HepG2) and adenocarcinoma (A549) cell lines. Compound 1-(N, N-dimethylbenzenamine)-3-(4-(p-tolylmethanimine)-5-thio-1, 2, 4-triazol-3-yl) β-carboline (9) was found to be most potent against both cancer cell lines and equipotent towards standard drug Adriamycin. Compounds 1-(p-tolyl)-3-(4-(p-(iminomethyl)-N, N-dimethylbenzenamine) -5-thio-1, 2, 4-triazol-3-yl) β-carboline (4) and 1-(N, N-dimethylbenzenamine)-3-(4-(m-tolylmethanimine)-5-thio-1, 2, 4-triazol-3-yl) β-carboline (10) were found to be 7 to 10 times less potent as compared to Adriamycin against the HepG2 cell line. Molecular docking was also performed with the Glide docking program to explore the binding mode between the synthesized β-carboline derivatives and the receptor CDK2 [1AQ1] protein.
Collapse
|
2
|
Hammoud MM, Nageeb AS, Morsi MA, Gomaa EA, Elmaaty AA, Al-Karmalawy AA. Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers. NEW J CHEM 2022. [DOI: 10.1039/d2nj01646j] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Novel cyclopentaquinoline derivatives as promising DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers.
Collapse
Affiliation(s)
- Mohamed M. Hammoud
- Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
- Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
| | - Alaa S. Nageeb
- Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
| | - M. A. Morsi
- Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
| | - Esam A. Gomaa
- Department of Chemistry, Faculty of Science, Mansoura University, Mansoura 35516, Egypt
| | - Ayman Abo Elmaaty
- Department of Medicinal Chemistry, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt
| | - Ahmed A. Al-Karmalawy
- Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt
| |
Collapse
|
3
|
Yadav P, Yadav R, Jain S, Vaidya A. Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug Des 2021; 98:144-165. [PMID: 33963665 DOI: 10.1111/cbdd.13860] [Citation(s) in RCA: 54] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2021] [Revised: 03/29/2021] [Accepted: 04/18/2021] [Indexed: 12/21/2022]
Abstract
Caspases, a group of protease enzymes (cysteine proteases), exist as inactive zymogens in the cells and execute apoptosis (programmed cell death). Caspase-3, an executioner caspase, plays an imperative role in apoptosis and becomes a primary target for cancer treatment. A number of analogues of quinazoline, quinazolinone, indoloquinazolines, quinone, naphthoquinones, pyrroloiminoquinones, styrylquinolines, tetheredtetrahydroquinoline, fluoroquinolone, thiosemicarbazones, benzotriazole, pyrimidines, chalcone, and carbazoles have been reported till date, representing caspase-3 mediated apoptosis for cancer therapy. Simultaneously, plant isolates, including lysicamine, podophyllotoxin, and majoranolide, have also been claimed for caspase-3-mediated apoptosis-induced cytotoxicity. Procaspase-activating compound-1 (PAC-1) is the first FDA approved orphan drug, and its synthetic derivative WF-208 also showed fascinating caspase-3 mediated anticancer activity. Till date, a large number of compounds have been reported and patented for their caspase-3-mediated cytotoxicity and now scientist is also focusing to introduce new compounds in market to encompass anticancer activity.
Collapse
Affiliation(s)
- Poonam Yadav
- Department of Pharmacology and Toxicology, NIPER, Hajipur, India
| | - Ramakant Yadav
- Department of Neurology, Uttar Pradesh University of Medical Sciences, Saifai, India
| | - Shweta Jain
- Sir Madan Lal Institute of Pharmacy, Etawah, India
| | - Ankur Vaidya
- Pharmacy College Saifai, Uttar Pradesh University of Medical Sciences, Saifai, India
| |
Collapse
|
4
|
Discovery of Novel 1,2,4-Oxadiazole Derivatives as Potent Caspase-3 Activator for Cancer Treatment. CHEMISTRY 2021. [DOI: 10.3390/chemistry3010027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
In the present study, a quantitative structure–activity relationship (QSAR) and docking studies were accomplished on a series of 1,2,4-oxadiazoles. The results of QSARs are reliable and have high predictive ability for both the internal (q2 = 0.610) and external (pred_r2 = 0.553) datasets with least standard error (SE; i.e., 0.130) and four principal components, which signifies the reliability of the generated model. Molecular docking was also reported by the GOLD docking program, which showed that the hydrogen bonding may be responsible for the activity, and may be further increased upon adding high electronegative substitutions.
Collapse
|
5
|
Pandit YB, Jiang YT, Jian JJ, Chen TC, Kuo TC, Cheng MJ, Liu RS. Gold-catalyzed [5 + 2]-annulations of 1,3-diyn-1-amides with anthranils bearing no C(6)-substituents. Org Chem Front 2021. [DOI: 10.1039/d1qo00026h] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
This work reports the gold-catalyzed [5 + 2]-annulations of commonly used anthranils with 1,3-diynamides, yielding quiniline oxides as the main products.
Collapse
Affiliation(s)
| | - Yan-Ting Jiang
- Department of Chemistry
- National Tsing-Hua University
- Hsinchu
- Republic of China
| | - Jia-Jyun Jian
- Department of Chemistry
- National Tsing-Hua University
- Hsinchu
- Republic of China
| | - Tai-Chi Chen
- Department of Biomedical Engineering and Enviornmental Science
- National Tsing-Hua University
- Hsinchu
- Republic of China
| | - Tung-Chun Kuo
- Department of Chemistry
- National Cheng Kung University
- Tainan
- Taiwan
| | - Mu-Jeng Cheng
- Department of Chemistry
- National Cheng Kung University
- Tainan
- Taiwan
| | - Rai-Shung Liu
- Department of Chemistry
- National Tsing-Hua University
- Hsinchu
- Republic of China
| |
Collapse
|
6
|
Vaidya A, Jain S, Prashantha Kumar B, Singh SK, Kashaw SK, Agrawal RK. Synthesis of 1,2,4-oxadiazole derivatives: anticancer and 3D QSAR studies. MONATSHEFTE FUR CHEMIE 2020. [DOI: 10.1007/s00706-020-02553-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
7
|
Design, Synthesis, and In Vitro Evaluation of Benzofuro[3,2- c]Quinoline Derivatives as Potential Antileukemia Agents. Molecules 2020; 25:molecules25010203. [PMID: 31947824 PMCID: PMC6983037 DOI: 10.3390/molecules25010203] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2019] [Revised: 12/30/2019] [Accepted: 01/01/2020] [Indexed: 11/16/2022] Open
Abstract
Herein, we design and synthesize an array of benzofuro[3,2-c]quinolines starting from 3-(2-methoxyphenyl)quinolin-4(1H)ones via a sequential chlorination/demethylation, intramolecular cyclization pathway. This sequential transformation was efficient, conducted under metal-free and mild reaction conditions, and yielded corresponding benzofuro[3,2-c]quinolines in high yields. In vitro biological evaluation indicated that such type of compounds showed excellent antileukemia activity and selectivity, and therefore may offer a promising hit compound for developing antileukemia compounds.
Collapse
|
8
|
Abdelbaset MS, Abdel-Aziz M, Ramadan M, Abdelrahman MH, Abbas Bukhari SN, Ali TF, Abuo-Rahma GEDA. Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors. Bioorg Med Chem 2019; 27:1076-1086. [DOI: 10.1016/j.bmc.2019.02.012] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2018] [Revised: 02/03/2019] [Accepted: 02/04/2019] [Indexed: 12/13/2022]
|
9
|
Abdelbaset MS, Abdel-Aziz M, Abuo-Rahma GEDA, Abdelrahman MH, Ramadan M, Youssif BGM. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities. Arch Pharm (Weinheim) 2018; 352:e1800270. [PMID: 30500087 DOI: 10.1002/ardp.201800270] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2018] [Revised: 10/21/2018] [Accepted: 10/30/2018] [Indexed: 11/11/2022]
Abstract
Novel quinoline derivatives carrying nitrones and oxime as nitric oxide donors were prepared and characterized using different spectroscopic techniques. Nitrones can release nitric oxide in larger amounts compared to corresponding oximes. Antiproliferative screening results showed that the 2-benzylthioquinoline nitrones 6e and 6f and the 2-methylthio analogues 6g and 6h exhibited promising antiproliferative activity especially against leukemia and colon cancer cell lines. Compounds 6c, 6e, and 6f exhibited higher potency as anticancer agents compared to doxorubicin, with IC50 ranging from 0.45 to 0.91 μM. A remarkable overexpression of caspase-3 protein levels was observed in cells treated with the tested compounds. Compound 6e exhibited more pre-G1 apoptosis and cell cycle arrest at the G2/M phase than in other phases. These results revealed that the tested compounds can cause programmed cell death through overexpression of caspase 3, which may be attributed to the release of nitric oxide.
Collapse
Affiliation(s)
- Mahmoud S Abdelbaset
- Faculty of Pharmacy, Department of Pharmaceutical Organic Chemistry, Al-Azhar University, Assiut, Egypt
| | - Mohamed Abdel-Aziz
- Faculty of Pharmacy, Department of Medicinal Chemistry, Minia University, Minia, Egypt
| | | | - Mostafa H Abdelrahman
- Faculty of Pharmacy, Department of Pharmaceutical Organic Chemistry, Al-Azhar University, Assiut, Egypt
| | - Mohamed Ramadan
- Faculty of Pharmacy, Department of Pharmaceutical Organic Chemistry, Al-Azhar University, Assiut, Egypt
| | - Bahaa G M Youssif
- Faculty of Pharmacy, Department of Pharmaceutical Organic Chemistry, Assiut University, Assiut, Egypt.,Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia
| |
Collapse
|
10
|
Abdelbaset MS, Abuo-Rahma GEDA, Abdelrahman MH, Ramadan M, Youssif BG, Bukhari SNA, Mohamed MF, Abdel-Aziz M. Novel pyrrol-2(3H)-ones and pyridazin-3(2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors. Bioorg Chem 2018; 80:151-163. [DOI: 10.1016/j.bioorg.2018.06.003] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2018] [Revised: 05/31/2018] [Accepted: 06/01/2018] [Indexed: 10/14/2022]
|